nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—CYP1A1—Dacarbazine—muscle cancer	0.112	1	CbGbCtD
Isoprenaline—PIK3R2—renal system—muscle cancer	0.0202	0.0857	CbGeAlD
Isoprenaline—PIK3R2—head—muscle cancer	0.0135	0.0574	CbGeAlD
Isoprenaline—ADRBK1—embryo—muscle cancer	0.0107	0.0454	CbGeAlD
Isoprenaline—PIK3R3—tendon—muscle cancer	0.0107	0.0454	CbGeAlD
Isoprenaline—MAPK1—embryo—muscle cancer	0.0105	0.0448	CbGeAlD
Isoprenaline—PIK3R1—cardiac atrium—muscle cancer	0.0105	0.0445	CbGeAlD
Isoprenaline—PIK3R3—vagina—muscle cancer	0.00992	0.0421	CbGeAlD
Isoprenaline—PIK3R3—head—muscle cancer	0.00916	0.0389	CbGeAlD
Isoprenaline—PIK3R1—tendon—muscle cancer	0.00913	0.0388	CbGeAlD
Isoprenaline—PIK3R3—testis—muscle cancer	0.00885	0.0376	CbGeAlD
Isoprenaline—PIK3R1—bone marrow—muscle cancer	0.00885	0.0376	CbGeAlD
Isoprenaline—PIK3R1—vagina—muscle cancer	0.00847	0.036	CbGeAlD
Isoprenaline—ADRBK1—smooth muscle tissue—muscle cancer	0.00841	0.0357	CbGeAlD
Isoprenaline—MAPK1—smooth muscle tissue—muscle cancer	0.00829	0.0352	CbGeAlD
Isoprenaline—ADRBK1—renal system—muscle cancer	0.00809	0.0344	CbGeAlD
Isoprenaline—MAPK1—renal system—muscle cancer	0.00798	0.0339	CbGeAlD
Isoprenaline—PIK3R1—testis—muscle cancer	0.00756	0.0321	CbGeAlD
Isoprenaline—MAPK1—cardiac atrium—muscle cancer	0.00714	0.0304	CbGeAlD
Isoprenaline—ADRBK1—bone marrow—muscle cancer	0.00612	0.026	CbGeAlD
Isoprenaline—MAPK1—bone marrow—muscle cancer	0.00603	0.0256	CbGeAlD
Isoprenaline—ADRBK1—vagina—muscle cancer	0.00586	0.0249	CbGeAlD
Isoprenaline—MAPK1—vagina—muscle cancer	0.00578	0.0245	CbGeAlD
Isoprenaline—ADRBK1—head—muscle cancer	0.00542	0.023	CbGeAlD
Isoprenaline—MAPK1—head—muscle cancer	0.00534	0.0227	CbGeAlD
Isoprenaline—ADRBK1—testis—muscle cancer	0.00523	0.0222	CbGeAlD
Isoprenaline—MAPK1—testis—muscle cancer	0.00516	0.0219	CbGeAlD
Isoprenaline—ADRB1—cardiac atrium—muscle cancer	0.00303	0.0129	CbGeAlD
Isoprenaline—ADRB1—head—muscle cancer	0.00227	0.00963	CbGeAlD
Isoprenaline—CYP1A1—renal system—muscle cancer	0.00218	0.00928	CbGeAlD
Isoprenaline—CYP1A1—cardiac atrium—muscle cancer	0.00196	0.00831	CbGeAlD
Isoprenaline—CYP1A1—vagina—muscle cancer	0.00158	0.00672	CbGeAlD
Isoprenaline—CYP1A1—head—muscle cancer	0.00146	0.00621	CbGeAlD
Isoprenaline—PIK3R3—Innate Immune System—KIT—muscle cancer	0.000309	0.000473	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CD34—muscle cancer	0.000304	0.000465	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—ENO2—muscle cancer	0.000303	0.000465	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—CNR1—muscle cancer	0.000301	0.000462	CbGpPWpGaD
Isoprenaline—MAPK1—Alzheimers Disease—TP53—muscle cancer	0.000301	0.000461	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—CNR1—muscle cancer	0.000297	0.000455	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—PTCH1—muscle cancer	0.000297	0.000455	CbGpPWpGaD
Isoprenaline—PIK3R3—Adaptive Immune System—KIT—muscle cancer	0.000297	0.000454	CbGpPWpGaD
Isoprenaline—MAPK1—Downstream signal transduction—MDM2—muscle cancer	0.000296	0.000454	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—FOXO4—muscle cancer	0.000295	0.000452	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by FGFR—MDM2—muscle cancer	0.000295	0.000452	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by VEGF—VEGFA—muscle cancer	0.000295	0.000452	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by ERBB2—MDM2—muscle cancer	0.000293	0.00045	CbGpPWpGaD
Isoprenaline—PIK3R1—TGF-beta Signaling Pathway—TP53—muscle cancer	0.000293	0.000449	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 signaling—MDM2—muscle cancer	0.000292	0.000448	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways in Glioblastoma—TP53—muscle cancer	0.000292	0.000447	CbGpPWpGaD
Isoprenaline—MAPK1—Glucocorticoid receptor regulatory network—TP53—muscle cancer	0.000292	0.000447	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—PTCH1—muscle cancer	0.00029	0.000445	CbGpPWpGaD
Isoprenaline—PIK3R1—Focal Adhesion—VEGFA—muscle cancer	0.00029	0.000445	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—ENO2—muscle cancer	0.000289	0.000442	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—ENO2—muscle cancer	0.000284	0.000436	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle, Mitotic—BUB1B—muscle cancer	0.000282	0.000433	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by NGF—MDM2—muscle cancer	0.000275	0.000422	CbGpPWpGaD
Isoprenaline—MAPK1—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	0.000275	0.000421	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by FGFR in disease—MDM2—muscle cancer	0.000275	0.000421	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 interactions—MDM2—muscle cancer	0.000275	0.000421	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—CNR1—muscle cancer	0.000274	0.000419	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR—MDM2—muscle cancer	0.000272	0.000417	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular Senescence—CDKN2A—muscle cancer	0.000272	0.000417	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR in Cancer—MDM2—muscle cancer	0.00027	0.000414	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—CNR1—muscle cancer	0.00027	0.000413	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by PDGF—MDM2—muscle cancer	0.000269	0.000412	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—KIDINS220—muscle cancer	0.000268	0.000411	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—MED12—muscle cancer	0.000265	0.000406	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular Senescence—MDM2—muscle cancer	0.000264	0.000405	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—PTCH1—muscle cancer	0.000263	0.000403	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—HMGA1—muscle cancer	0.000262	0.000402	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—FOXO1—muscle cancer	0.000262	0.000401	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000259	0.000396	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—HMGA1—muscle cancer	0.000258	0.000396	CbGpPWpGaD
Isoprenaline—PIK3R1—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000257	0.000394	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—PTCH1—muscle cancer	0.000256	0.000393	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—FOXO4—muscle cancer	0.000255	0.00039	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—BUB1B—muscle cancer	0.000253	0.000387	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—FOXO1—muscle cancer	0.000251	0.000385	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—FOXO4—muscle cancer	0.000251	0.000385	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—CNR1—muscle cancer	0.00025	0.000384	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000249	0.000382	CbGpPWpGaD
Isoprenaline—MAPK1—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000249	0.000382	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—KIT—muscle cancer	0.000246	0.000377	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—CNR1—muscle cancer	0.000245	0.000375	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—CNR1—muscle cancer	0.000244	0.000374	CbGpPWpGaD
Isoprenaline—MAPK1—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000243	0.000373	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—MDM2—muscle cancer	0.000243	0.000373	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—KIT—muscle cancer	0.000242	0.000372	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—ENO2—muscle cancer	0.000242	0.00037	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—FOXO4—muscle cancer	0.000241	0.000369	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—PTCH1—muscle cancer	0.00024	0.000368	CbGpPWpGaD
Isoprenaline—MAPK1—Senescence and Autophagy in Cancer—TP53—muscle cancer	0.000239	0.000367	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—CNR1—muscle cancer	0.000238	0.000365	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—KIT—muscle cancer	0.000238	0.000364	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000237	0.000363	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	0.000237	0.000363	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—KIT—muscle cancer	0.000236	0.000362	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—FOXO1—muscle cancer	0.000236	0.000362	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—FOXO4—muscle cancer	0.000235	0.00036	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—ENO2—muscle cancer	0.000234	0.000358	CbGpPWpGaD
Isoprenaline—PIK3R3—Adaptive Immune System—MDM2—muscle cancer	0.000234	0.000358	CbGpPWpGaD
Isoprenaline—MAPK1—DNA Damage Response (only ATM dependent)—TP53—muscle cancer	0.000232	0.000356	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—FOXO4—muscle cancer	0.000232	0.000355	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—KIDINS220—muscle cancer	0.000228	0.00035	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—KIDINS220—muscle cancer	0.000223	0.000342	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—CNR1—muscle cancer	0.000222	0.00034	CbGpPWpGaD
Isoprenaline—MAPK1—Spinal Cord Injury—TP53—muscle cancer	0.000218	0.000334	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—FOXO1—muscle cancer	0.000218	0.000334	CbGpPWpGaD
Isoprenaline—MAPK1—Oxidative Stress Induced Senescence—TP53—muscle cancer	0.000217	0.000332	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—CNR1—muscle cancer	0.000216	0.000332	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—MED12—muscle cancer	0.000215	0.000329	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—IGF2—muscle cancer	0.000215	0.000329	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—HMGA1—muscle cancer	0.000212	0.000326	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—FOXO4—muscle cancer	0.000207	0.000317	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—FOXO4—muscle cancer	0.000206	0.000316	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD34—muscle cancer	0.000206	0.000316	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—CDKN2A—muscle cancer	0.000206	0.000315	CbGpPWpGaD
Isoprenaline—PIK3R3—Hemostasis—VEGFA—muscle cancer	0.000205	0.000314	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CNR1—muscle cancer	0.000203	0.000311	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—FOXO1—muscle cancer	0.000201	0.000309	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—MDM2—muscle cancer	0.0002	0.000306	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—KIT—muscle cancer	0.000199	0.000306	CbGpPWpGaD
Isoprenaline—MAPK1—TGF-beta Signaling Pathway—TP53—muscle cancer	0.000199	0.000306	CbGpPWpGaD
Isoprenaline—MAPK1—Focal Adhesion—VEGFA—muscle cancer	0.000197	0.000302	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000196	0.000301	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—ENO2—muscle cancer	0.000196	0.0003	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—MDM2—muscle cancer	0.000194	0.000297	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—PTCH1—muscle cancer	0.000192	0.000294	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—KIT—muscle cancer	0.000191	0.000293	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—MDM2—muscle cancer	0.000191	0.000293	CbGpPWpGaD
Isoprenaline—MAPK1—Neuronal System—MDM2—muscle cancer	0.000191	0.000293	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—FOXO4—muscle cancer	0.000191	0.000292	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000189	0.00029	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—PTCH1—muscle cancer	0.000189	0.000289	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—FOXO1—muscle cancer	0.000188	0.000288	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—MDM2—muscle cancer	0.000187	0.000287	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—MDM2—muscle cancer	0.000186	0.000285	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—FOXO1—muscle cancer	0.000185	0.000284	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000182	0.000279	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—KIT—muscle cancer	0.00018	0.000276	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Breast Cancer Pathway—TP53—muscle cancer	0.000179	0.000274	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—PTCH1—muscle cancer	0.000179	0.000274	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—FOXO1—muscle cancer	0.000178	0.000273	CbGpPWpGaD
Isoprenaline—MAPK1—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000175	0.000268	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—FOXO1—muscle cancer	0.000174	0.000266	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—FOXO1—muscle cancer	0.000171	0.000262	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—KIT—muscle cancer	0.000166	0.000254	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IGF2—muscle cancer	0.000166	0.000254	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—FOXO4—muscle cancer	0.000165	0.000252	CbGpPWpGaD
Isoprenaline—MAPK1—MAPK Signaling Pathway—TP53—muscle cancer	0.000164	0.000252	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—VEGFA—muscle cancer	0.000164	0.000251	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—FOXO4—muscle cancer	0.000162	0.000249	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CNR1—muscle cancer	0.000162	0.000248	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CNR1—muscle cancer	0.000159	0.000244	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—ENO2—muscle cancer	0.000159	0.000244	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—MDM2—muscle cancer	0.000157	0.000241	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—PTCH1—muscle cancer	0.000155	0.000238	CbGpPWpGaD
Isoprenaline—PIK3R3—Hemostasis—TP53—muscle cancer	0.000155	0.000238	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000153	0.000235	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—FOXO1—muscle cancer	0.000153	0.000234	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—FOXO1—muscle cancer	0.000152	0.000234	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—PTCH1—muscle cancer	0.000152	0.000233	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—VEGFA—muscle cancer	0.000152	0.000232	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular Senescence—TP53—muscle cancer	0.000152	0.000232	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—PTCH1—muscle cancer	0.000151	0.000232	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—MDM2—muscle cancer	0.000151	0.000231	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CNR1—muscle cancer	0.000151	0.000231	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—PTCH1—muscle cancer	0.000149	0.000228	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000148	0.000227	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—HMGA1—muscle cancer	0.000144	0.000221	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—KIT—muscle cancer	0.000143	0.00022	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—FH—muscle cancer	0.000143	0.00022	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—MDM2—muscle cancer	0.000142	0.000217	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—CNR1—muscle cancer	0.000141	0.000217	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—KIT—muscle cancer	0.000141	0.000216	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—FOXO1—muscle cancer	0.000141	0.000216	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—FOXO4—muscle cancer	0.00014	0.000215	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—CNR1—muscle cancer	0.000138	0.000212	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—KIT—muscle cancer	0.000136	0.000208	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—FOXO4—muscle cancer	0.000133	0.000205	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—VEGFA—muscle cancer	0.000132	0.000203	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—KIT—muscle cancer	0.000132	0.000203	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IGF2—muscle cancer	0.000132	0.000203	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CNR1—muscle cancer	0.000131	0.000201	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—MDM2—muscle cancer	0.000131	0.0002	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—KIT—muscle cancer	0.00013	0.0002	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—FOXO4—muscle cancer	0.00013	0.0002	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IGF2—muscle cancer	0.00013	0.0002	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—FOXO4—muscle cancer	0.00013	0.000199	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle, Mitotic—CDKN2A—muscle cancer	0.000129	0.000198	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—VEGFA—muscle cancer	0.000129	0.000197	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CNR1—muscle cancer	0.000128	0.000197	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CNR1—muscle cancer	0.000128	0.000196	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—PTGS2—muscle cancer	0.000126	0.000193	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CNR1—muscle cancer	0.000126	0.000193	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—TP53—muscle cancer	0.000124	0.000189	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—FOXO1—muscle cancer	0.000122	0.000186	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—FOXO1—muscle cancer	0.00012	0.000184	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—KIT—muscle cancer	0.000116	0.000178	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—KIT—muscle cancer	0.000116	0.000178	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—CDKN2A—muscle cancer	0.000115	0.000177	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—TP53—muscle cancer	0.000115	0.000175	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—MDM2—muscle cancer	0.000113	0.000173	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—MDM2—muscle cancer	0.000112	0.000172	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—MDM2—muscle cancer	0.000111	0.00017	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—KIT—muscle cancer	0.000107	0.000164	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IGF2—muscle cancer	0.000107	0.000164	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—MDM2—muscle cancer	0.000107	0.000164	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—PTGS2—muscle cancer	0.000106	0.000162	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PTCH1—muscle cancer	0.000105	0.000162	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IGF2—muscle cancer	0.000105	0.00016	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—MDM2—muscle cancer	0.000104	0.00016	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—FOXO1—muscle cancer	0.000104	0.000159	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—MDM2—muscle cancer	0.000103	0.000157	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—PTGS2—muscle cancer	0.0001	0.000154	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—TP53—muscle cancer	0.0001	0.000153	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—PTGS2—muscle cancer	9.9e-05	0.000152	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—FOXO1—muscle cancer	9.86e-05	0.000151	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—FOXO1—muscle cancer	9.62e-05	0.000147	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—FOXO1—muscle cancer	9.57e-05	0.000147	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—KIT—muscle cancer	9.27e-05	0.000142	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—VEGFA—muscle cancer	9.18e-05	0.000141	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MDM2—muscle cancer	9.16e-05	0.00014	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—MDM2—muscle cancer	9.15e-05	0.00014	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—KIT—muscle cancer	9.13e-05	0.00014	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—FOXO4—muscle cancer	9.07e-05	0.000139	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—VEGFA—muscle cancer	9.01e-05	0.000138	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PTCH1—muscle cancer	8.99e-05	0.000138	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CNR1—muscle cancer	8.9e-05	0.000136	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PTCH1—muscle cancer	8.79e-05	0.000135	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—MDM2—muscle cancer	8.45e-05	0.000129	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—PTGS2—muscle cancer	8.42e-05	0.000129	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—PTGS2—muscle cancer	8.14e-05	0.000125	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—MED12—muscle cancer	8.1e-05	0.000124	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—KIT—muscle cancer	7.9e-05	0.000121	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—FOXO4—muscle cancer	7.73e-05	0.000118	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CNR1—muscle cancer	7.59e-05	0.000116	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—FOXO4—muscle cancer	7.56e-05	0.000116	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—KIT—muscle cancer	7.51e-05	0.000115	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CNR1—muscle cancer	7.42e-05	0.000114	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ENO2—muscle cancer	7.38e-05	0.000113	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—KIT—muscle cancer	7.33e-05	0.000112	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MDM2—muscle cancer	7.3e-05	0.000112	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—KIT—muscle cancer	7.29e-05	0.000112	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IGF2—muscle cancer	7.28e-05	0.000112	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MDM2—muscle cancer	7.19e-05	0.00011	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—VEGFA—muscle cancer	6.95e-05	0.000107	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—PTGS2—muscle cancer	6.82e-05	0.000105	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—TP53—muscle cancer	6.8e-05	0.000104	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—FOXO1—muscle cancer	6.7e-05	0.000103	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—TP53—muscle cancer	6.42e-05	9.84e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—MDM2—muscle cancer	6.22e-05	9.53e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IGF2—muscle cancer	6.2e-05	9.51e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IGF2—muscle cancer	6.07e-05	9.3e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MDM2—muscle cancer	5.91e-05	9.06e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	5.77e-05	8.85e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MDM2—muscle cancer	5.77e-05	8.85e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—MDM2—muscle cancer	5.74e-05	8.8e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—FOXO1—muscle cancer	5.71e-05	8.75e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—FOXO1—muscle cancer	5.59e-05	8.56e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—VEGFA—muscle cancer	5.54e-05	8.5e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PTGS2—muscle cancer	5.53e-05	8.48e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—VEGFA—muscle cancer	5.46e-05	8.37e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TP53—muscle cancer	5.25e-05	8.05e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—KIT—muscle cancer	5.1e-05	7.82e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—VEGFA—muscle cancer	4.49e-05	6.88e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—VEGFA—muscle cancer	4.38e-05	6.72e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—KIT—muscle cancer	4.35e-05	6.67e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—KIT—muscle cancer	4.26e-05	6.52e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TP53—muscle cancer	4.19e-05	6.42e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TP53—muscle cancer	4.13e-05	6.32e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MDM2—muscle cancer	4.02e-05	6.16e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MDM2—muscle cancer	3.43e-05	5.25e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TP53—muscle cancer	3.39e-05	5.2e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MDM2—muscle cancer	3.35e-05	5.14e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TP53—muscle cancer	3.31e-05	5.08e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—VEGFA—muscle cancer	3.05e-05	4.68e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—VEGFA—muscle cancer	2.6e-05	3.99e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PTGS2—muscle cancer	2.57e-05	3.94e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—VEGFA—muscle cancer	2.55e-05	3.9e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TP53—muscle cancer	2.31e-05	3.54e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TP53—muscle cancer	1.97e-05	3.01e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TP53—muscle cancer	1.92e-05	2.95e-05	CbGpPWpGaD
